MMG CEO John Benbrook named to CISCRP board of advisors

Friday, March 18, 2011 10:47 AM

The Center for Information and Study on Clinical Research Participation (CISCRP) has named John Benbrook, CEO of MMG, a patient recruitment and retention company, to its board of advisors.

Benbrook has more than 20 years of experience in healthcare, pharmaceutical and life science organizations. He joined MMG as vice president in 2004 and became CEO in 2006. In 2009, Benbrook was named a partner at MMG's parent company Ketchum, a global communications consultancy.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs